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Multivadate Predictors of Patients without CRF Patients with CRF 
CIN OR (95%CI), p-value OR (95%Ci), p-value 
Diabetes 1.45 (1.26-1.67) 1.78 (1.34-2.37) p<0.0001 
p<0.O001 
Severe CHF 3.44 (2.54-4.65) 2.41 (1.55-3.73) p<0.0001 
p<0.0001 
Contrast/BSA ratio 1.02 (1.01=1.02) 1.01 (1.00-1.01) p<0.0001 
p<0.0001 
Creatinine Clearance 1.02 (1.01-1.02) 0.98 (0.98-0.99) p=0.0003 
p<0.0001 
Female Gender 1.25 (1.08-1.43) p=NS 
p=0.0047 
Age 1.04 (1.03-1.05) p=NS 
p<O.0001 
1173-8 Intracoronary Beta-Radiation Therapy for Long Lesions 
in Native Coronary Vessels 
Goran R. Stankovic, Antonio Colombo, Carlo Di Mado, Remo AIbiero, Nicala Corvaja, 
Takuro Takagi, Konstantinos Toutouzas, Antonio Amato, Ginevra Sivied, Roberto 
Orecohia, Centro Cuore Columbus, Milan, Italy 
Background: This study evaluates early and late clinical and angiographic outcome of 
patients with long (>20mm) de novo or in-stent restenotic lesions in native coronary ves- 
sels treated with beta radiation for restenosis prevention. 
Methods and results: Between April 1999 and December 2000, 84 consecutive patients, 
with 117 lesions longer than 20ram in native coronary vessels, were successfully treated 
using 90-Strontium/Yttrium radiation source. The reference vessel size was 2.49±0.5 
mm, and the mean lesion length 28.7±8.6 mm. Stents were implanted in 43.6% of the 
lesions. Radiation dose delivered was 16.5±3.3 Gy at 2 mm from the center of the 
source, with a mean dwell time of 269¢122 sac, and using manual pullback technique in 
21% of lesions. Ticlopidine was prescribed for 3 months in the first 29 patients, subse- 
quently for 6 months without stenting or for 1 year with stent implantation. Clinical follow- 
up was obtained for all patients after 16.4±6.7 months. Major adverse cardiac events, a 
composite of death, Q-wave myocardial infarction and target lesion revascularization, 
occurred in 19 patients (22.6%). Late thrombosis occurred in 2 patients (2.4%) treated 
with stents at the time of radiation, and after discontinuation of ticlopidine. 
Follow-up angiography was performed in 74 patients (88%). Angiographic restenosis 
(>50% diameter stenosis of the analysis segment) was present in 27/103 lesions 
(26.2%). Target lesion and target vessel revasculadzation rates were 21.4% and 30.8%, 
respectively. 
Conciusiom Intracoronary beta radiation can be safely and effectively used to treat long 
coronary lesions. Long term combined antipiatelet herapy is necessary for patients who 
receive new stents at the time of the radiation treatment. 
1173-9 Efficacy of Long Radiation Treatment in Native In-Stent 
Restenosis: A Subanalysis From the RENO Registry 
Dietrich Baumoart. T. Limpijankif, P. Serruys, A. Colombo, S. Silber, E. Eeckhout, P. 
Urban, R. Bonan, A. Zeiher, A. H. Gershlick, G. Dangas, A. A. Lansky, R. Mehran, G. W. 
Stone, M. B. Leon, Cardiovascular Research Foundation, New York, New York, 
University of Essen, Essen, Germany. 
Background: The effectiveness of intracoronary radiation therapy of diffuse in-stent rest- 
enosis (ISR) with Strontium-90 Beta sources is unknown. 
Methods: The RENO registry is a post market prospective surveillance study enrolling 
consecutive patients with iSR at 46 European centers using the Novoste Beta-Cath TM 
system. Patients were treated with approved interventional devices, followed by Stren- 
tium-9O Beta-radiation treatment. Of the 1098 patients enrolled in the trial, 139 had dif- 
fuse native coronary ISR treated with a stepping technique using a 30, 40, or 60mm 
source train or a single 60mm source train. The historical control group was the placebo 
arm of the WRIST and LONG WRIST studies (N=94). 
Results: Baseline characteristics were similar between two groups except for more dia- 
betics in placebo. Brachytherapy success (<50% residual stenosis and successful deliv- 
ery of the radiation device) was 99.3% in the RENO group. Clinical follow-up at 6 months 
was available in >96%. The results are shown in the table. 
Conclusion: Beta-radiation with Sr-90 using either a stepping (pullback) technique or a 
single 60mm source train to treat patients with diffuse, long native ISR lesions is effective 
and results in significant reductions in TVR by 75% and MACE by 72% without any 
increase in the late thrombosis rates compared to historical controls. 
RENO Long Radiation WRIST Placebo p-Value 
(N=139) (N=94) 
Diabetes (%) 21.9% 37.2% 0.02 
Lesion length (mm) 35.33 ± 17.89 27.97 ± 11.84 0.0003 
TVR at 5 months 14.9% 60.6% <0.0001 
MACE at 6 months 17.9% 64.9% <0.0001 
Total occlusion at 6 months 12.2% 9.9% NS 
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1173-10 Feasib i l i ty  and Safety  of  a Novel  Cryoang iop leaty  
System 
Mitsuvasu Terashima, Yasuhiro Honda, Frederick S. Goar, James D. Joye, Kristine 
Tatsutani, Margaret Yoklavich, Paul G. Yock, Peter J. Fitzgerald, Stanford University 
Stanford, California. El Cam/no Hospital, Mountain View, California. 
Background: Previous cryosurgical studies have indicated that freezing arterial tissues 
in vivo is followed by a benign healing process largely devoid of neointimal proliferation, 
suggesting a potential beneficial impact on restenosis following intervention. This study is 
designed to evaluate feasibility and safety of a newly developed cryoangioplasty (CP) 
system in a porcine coronary model. 
Methods: The cryoangioplasty system (CryoPlasty TM, CryoVascular Systems, Inc.) con- 
sists of a baltoon-besed catheter and an inflation unit, which delivers tiqutd nitrous oxide 
through the catheter and inflates the balloon to a predetermined pressure and tempera- 
ture. We assessed the safety and performance characteristics of CP system at a sub- 
zero treatment emperature, compared with those of e control treatment (conventional 
PTCA) using a similar balloon to artery ratio and pressure conditions. Twelve animals 
were assigned to 3-day or 28-day follow-up (6 animals per group). Each animal under- 
went PTCA in one of the coronary arteries and CP in up to two of the remaining arteries 
(6 vessels with PTCA in both groups, 9 vessels and 12 vessels with CP in 3-day and 28- 
day follow-up, respectively). Angiogrephy was performed at baseline, following treat- 
ment, and follow-up, and changes in lumen diameter and % diameter stsnosis were ana- 
lyzed by quantitative coronary angiography. 
Results: No adverse events (including side branch occlusion or distal coronary flow limi- 
tation) were observed in any group. No significant loss of lumen diameter or increment of 
% diameter stsnosis was found at either 3-day or 28-day follow-up in the CP group. At 
28-day follow-up, mean % diameter stenosis in the CP group was 4.6%, compared with 
12.5% in the PTCA group (p<0.05). 
Conclusions: This study demonstrates the feasibility and safety of the cryoangioplasty 
system for use in the coronary arteries and a possible beneficial effect on chronic vascu- 
lar reaction following intervention. 
11 73-11 Are Older Women, Compared to Older Men, at Higher 
Risk During Percutaneous Coronary Intervention? 
Results From the Danish PTCA Registry 
Lisette O. Jensen. Per Thayssen, Eli Kassis, Klaus Rasmussen, Karl Saunam&ki, Leif 
Thuesen, Department of Cardiology Odense University Hospital, Odense, Denmark. 
BackgroundOIder patients are at higher risk during percutaneous coronary intervention 
(PCI). Whether this increased risk is gender related is not known. In order to evaluate this 
issue further, data from the Danish PTCA Registry were analysed for the 3-year period 
1996-1998. During this period data from all PCI procedures in Denmark were prospec- 
tively recorded in a central database. 
Methods Angiographic baseline characteristics, outcome of PCI and procedural compli- 
cations were analysed in a total of 8.187 consecutive procedures (6.896 patients, 11.472 
lesions dilated). 
Results In patients <_ 70 year women were significantly older than men (58.0 vs. 56.5; p 
< 0.0001), but no significant gender difference in age was seen in patients • 70 year. 
< 70 year > 70 year p 
men women men women 
Number of patients 5.242 1.654 822 469 
Age (Year) 56.5 58.0 74.8 75.0 
Left ventricle ejection fraction (%) 60.3 62.1 56.5 61.1 
Coronary narrowing severity (%) 84.6 83.2 84.8 84.2 
Number of 1 vessel disease (%) 60.1 69.2 45.5 53.9 
Angiographic primary success 87.8 89.2 87.1 85.8 
rate (%) 
Rate of stenting (%) 58.1 56.2 58.6 57.9 
MACE (%) 4.2 4.9 8.4 10,4 
Emergency CABG (%) 0.9 1.0 1.0 1.3 
Myocardial infarction (%) 2.9 3.7 5,8 6.6 
Death (%) 0.4 0.2 1.6 2,6 
M = men, w = women; MACE = major adverse coronary events (emergency CABG, non- 
fatal myocardial infarction (q-wave and non-q-wave myocardial infarction), and death) 
within 24 hours after index procedure. 
*age but not gender as independent predictor, p < 0.0001 
**age and gender as independent predictor, p < 0.0001 
Logistic regression analysis showed, that age, but not gender, was an independent pre- 
dictor of angiographic primary success rate, MACE, myocardial infarction and death. 
ConcluslonOIder patients had significant more complications after PCI, however no sig- 
nificant gender difference with regard to complications after PCI, neither in patients -< 70 
year nor in patients > 70 year could be demonstrated. 
